as we all wait for the clinical results on xB3 004, xB3 007 and xB3 progranulin, it's now becoming apparent that those results will now be forthcoming (we hope) in CY Q2 2021.  However, there are some who will not wait, specifically the seller from house #2, who has now sold somewhere between 1 and 2 million shares over the past month+ (and that may be on the low side).  We can't be certain of the timing of our results, but we can be certain of the determination of #2 to sell, sell, sell.  This is not conjecture.